Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

Eli Lilly · Phase 3 · Recruiting · Enrollment 150

NCT06672939

ArmPopulationDoseWeeksEstimandWeight change
OrforglipronObesity or overweightn/r156n/rn/r
PlaceboObesity or overweightn/r156n/rn/r